Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Buy
63
CVX Quote, Financials, Valuation and Earnings
Last price:
$166.05
Seasonality move
:
2.78%
Day range:
$165.85 - $168.22
52-week range:
$135.37 - $168.96
Dividend yield:
3.96%
P/E ratio:
17.15x
P/S ratio:
1.57x
P/B ratio:
1.93x
Volume:
6.8M
Avg. volume:
8.5M
1-year change:
6.59%
Market cap:
$293.4B
Revenue:
$193.4B
EPS (TTM):
$9.72
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $94.5B | $155.6B | $235.7B | $196.9B | $193.4B | |
| Revenue Growth (YoY) | -32.46% | 64.71% | 51.48% | -16.46% | -1.78% | |
| Cost of Revenues | $71.7B | $110.2B | $161.7B | $136.5B | $136.5B | |
| Gross Profit | $22.8B | $45.4B | $74B | $60.4B | $56.9B | |
| Gross Profit Margin | 24.15% | 29.2% | 31.39% | 30.67% | 29.43% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.2B | $4B | $4.3B | $4.1B | $4.8B | |
| Other Inc / (Exp) | -$659M | $6.2B | $10.2B | $3.8B | $9.2B | |
| Operating Expenses | $28.9B | $29.3B | $34B | $34.2B | $38B | |
| Operating Income | -$6.1B | $16.2B | $40B | $26.2B | $18.9B | |
| Net Interest Expenses | $697M | $712M | $516M | $469M | $594M | |
| EBT. Incl. Unusual Items | -$7.5B | $21.6B | $49.7B | $29.6B | $27.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.9B | $6B | $14.1B | $8.2B | $9.8B | |
| Net Income to Company | -$5.6B | $15.7B | $35.6B | $21.4B | $17.7B | |
| Minority Interest in Earnings | $18M | -$64M | -$143M | -$42M | -$88M | |
| Net Income to Common Excl Extra Items | -$5.5B | $15.6B | $35.5B | $21.4B | $17.7B | |
| Basic EPS (Cont. Ops) | -$2.96 | $8.15 | $18.36 | $11.41 | $9.76 | |
| Diluted EPS (Cont. Ops) | -$2.96 | $8.14 | $18.28 | $11.36 | $9.72 | |
| Weighted Average Basic Share | $1.9B | $1.9B | $1.9B | $1.9B | $1.8B | |
| Weighted Average Diluted Share | $1.9B | $1.9B | $1.9B | $1.9B | $1.8B | |
| EBITDA | $10.4B | $39.4B | $65.5B | $45B | $44.7B | |
| EBIT | -$6.8B | $22.4B | $50.2B | $30.1B | $28.1B | |
| Revenue (Reported) | $94.5B | $155.6B | $235.7B | $196.9B | $193.4B | |
| Operating Income (Reported) | -$6.1B | $16.2B | $40B | $26.2B | $18.9B | |
| Operating Income (Adjusted) | -$6.8B | $22.4B | $50.2B | $30.1B | $28.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $24.8B | $45.9B | $54.5B | $48.9B | $48.3B | |
| Revenue Growth (YoY) | -28.15% | 84.6% | 18.89% | -10.25% | -1.22% | |
| Cost of Revenues | $19.5B | $35B | $37.3B | $34.7B | $35.1B | |
| Gross Profit | $5.3B | $10.8B | $17.2B | $14.2B | $13.2B | |
| Gross Profit Margin | 21.37% | 23.62% | 31.53% | 29.02% | 27.34% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.1B | $1.3B | $1.5B | $969M | $1.6B | |
| Other Inc / (Exp) | -$58M | $2.2B | $1.9B | -$1.8B | $3.8B | |
| Operating Expenses | $6B | $5.9B | $9.2B | $8.8B | $10.8B | |
| Operating Income | -$700M | $5B | $8B | $5.4B | $2.4B | |
| Net Interest Expenses | $199M | $155M | $123M | $120M | $199M | |
| EBT. Incl. Unusual Items | -$957M | $7B | $9.8B | $3.5B | $6.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$301M | $1.9B | $3.4B | $1.2B | $2.8B | |
| Net Income to Company | -$656M | $5.1B | $6.4B | $2.2B | $3.3B | |
| Minority Interest in Earnings | -$9M | -$27M | -$25M | $16M | -$20M | |
| Net Income to Common Excl Extra Items | -$665M | $5.1B | $6.4B | $2.3B | $3.2B | |
| Basic EPS (Cont. Ops) | -$0.33 | $2.63 | $3.34 | $1.23 | $1.85 | |
| Diluted EPS (Cont. Ops) | -$0.33 | $2.63 | $3.33 | $1.22 | $1.84 | |
| Weighted Average Basic Share | $1.9B | $1.9B | $1.9B | $1.9B | $1.8B | |
| Weighted Average Diluted Share | $2.1B | $1.9B | $1.9B | $1.9B | $1.8B | |
| EBITDA | $564M | $11B | $13.4B | $7.2B | $10.3B | |
| EBIT | -$758M | $7.1B | $9.9B | $3.6B | $6.3B | |
| Revenue (Reported) | $24.8B | $45.9B | $54.5B | $48.9B | $48.3B | |
| Operating Income (Reported) | -$700M | $5B | $8B | $5.4B | $2.4B | |
| Operating Income (Adjusted) | -$758M | $7.1B | $9.9B | $3.6B | $6.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $94.5B | $155.6B | $235.7B | $196.9B | $193.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $71.7B | $110.2B | $161.7B | $136.5B | $136.5B | |
| Gross Profit | $22.8B | $45.4B | $74B | $60.4B | $56.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.2B | $4B | $4.3B | $4.1B | $4.8B | |
| Other Inc / (Exp) | -$659M | $6.2B | $10.2B | $3.8B | $9.2B | |
| Operating Expenses | $28.9B | $29.3B | $34B | $34.2B | $38B | |
| Operating Income | -$6.1B | $16.2B | $40B | $26.2B | $18.9B | |
| Net Interest Expenses | $697M | $712M | $516M | $469M | $594M | |
| EBT. Incl. Unusual Items | -$7.5B | $21.6B | $49.7B | $29.6B | $27.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.9B | $6B | $14.1B | $8.2B | $9.8B | |
| Net Income to Company | -$5.6B | $15.7B | $35.6B | $21.4B | $17.7B | |
| Minority Interest in Earnings | $18M | -$64M | -$143M | -$42M | -$88M | |
| Net Income to Common Excl Extra Items | -$5.5B | $15.6B | $35.5B | $21.4B | $17.7B | |
| Basic EPS (Cont. Ops) | -$2.96 | $8.15 | $18.36 | $11.41 | $9.76 | |
| Diluted EPS (Cont. Ops) | -$2.96 | $8.14 | $18.28 | $11.36 | $9.72 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $10.4B | $39.4B | $65.5B | $45B | $44.7B | |
| EBIT | -$6.8B | $22.4B | $50.2B | $30.1B | $28.1B | |
| Revenue (Reported) | $94.5B | $155.6B | $235.7B | $196.9B | $193.4B | |
| Operating Income (Reported) | -$6.1B | $16.2B | $40B | $26.2B | $18.9B | |
| Operating Income (Adjusted) | -$6.8B | $22.4B | $50.2B | $30.1B | $28.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $155.6B | $235.7B | $196.9B | $193.4B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $110.2B | $161.7B | $136.5B | $136.5B | -- | |
| Gross Profit | $45.4B | $74B | $60.4B | $56.9B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4B | $4.3B | $4.1B | $4.8B | -- | |
| Other Inc / (Exp) | $6.2B | $10.2B | $3.8B | $9.2B | -- | |
| Operating Expenses | $29.3B | $34B | $34.2B | $38B | -- | |
| Operating Income | $16.2B | $40B | $26.2B | $18.9B | -- | |
| Net Interest Expenses | $712M | $516M | $469M | $594M | -- | |
| EBT. Incl. Unusual Items | $21.6B | $49.7B | $29.6B | $27.5B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6B | $14.1B | $8.2B | $9.8B | -- | |
| Net Income to Company | $15.7B | $35.6B | $21.4B | $17.7B | -- | |
| Minority Interest in Earnings | -$64M | -$143M | -$42M | -$88M | -- | |
| Net Income to Common Excl Extra Items | $15.6B | $35.5B | $21.4B | $17.7B | -- | |
| Basic EPS (Cont. Ops) | $8.15 | $18.36 | $11.41 | $9.76 | -- | |
| Diluted EPS (Cont. Ops) | $8.14 | $18.28 | $11.36 | $9.72 | -- | |
| Weighted Average Basic Share | $7.7B | $7.7B | $7.5B | $7.2B | -- | |
| Weighted Average Diluted Share | $7.7B | $7.8B | $7.5B | $7.3B | -- | |
| EBITDA | $39.4B | $65.5B | $45B | $44.7B | -- | |
| EBIT | $22.4B | $50.2B | $30.1B | $28.1B | -- | |
| Revenue (Reported) | $155.6B | $235.7B | $196.9B | $193.4B | -- | |
| Operating Income (Reported) | $16.2B | $40B | $26.2B | $18.9B | -- | |
| Operating Income (Adjusted) | $22.4B | $50.2B | $30.1B | $28.1B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.6B | $5.6B | $17.7B | $8.2B | $6.8B | |
| Short Term Investments | $31M | $35M | $223M | $45M | $4M | |
| Accounts Receivable, Net | $11.5B | $18.4B | $20.5B | $19.9B | $20.7B | |
| Inventory | $5.7B | $6.8B | $8.2B | $8.6B | $9.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.3B | $2.8B | $3.7B | $4.4B | $4.4B | |
| Total Current Assets | $26.1B | $33.7B | $50.3B | $41.1B | $40.9B | |
| Property Plant And Equipment | $156.6B | $147B | $143.6B | $153.6B | $147.8B | |
| Long-Term Investments | $39.1B | $40.7B | $45.2B | $46.8B | $47.4B | |
| Goodwill | $4.4B | $4.4B | $4.7B | $4.7B | $4.6B | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $13.1B | $13.2B | $12.7B | $14.4B | $15.3B | |
| Total Assets | $239.8B | $239.5B | $257.7B | $261.6B | $256.9B | |
| Accounts Payable | $11B | $16.5B | $19B | $20.4B | $22.1B | |
| Accrued Expenses | $7.8B | $7B | $7.5B | $7.7B | $8.5B | |
| Current Portion Of Long-Term Debt | $1.4B | $208M | $1.9B | $469M | $4.3B | |
| Current Portion Of Capital Lease Obligations | $186M | $48M | $45M | $60M | $58M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $22.2B | $26.8B | $34.2B | $32.3B | $38.6B | |
| Long-Term Debt | $42.3B | $30.7B | $21B | $19.7B | $19.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $107.1B | $99.6B | $97.5B | $99.7B | $103.8B | |
| Common Stock | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| Other Common Equity Adj | -- | -- | -$12M | $5M | -$14M | |
| Common Equity | $131.7B | $139.1B | $159.3B | $161B | $152.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1B | $873M | $960M | $972M | $839M | |
| Total Equity | $132.7B | $139.9B | $160.2B | $161.9B | $153.2B | |
| Total Liabilities and Equity | $239.8B | $239.5B | $257.7B | $261.6B | $256.9B | |
| Cash and Short Terms | $5.6B | $5.7B | $17.9B | $8.2B | $6.8B | |
| Total Debt | $43.7B | $30.9B | $22.9B | $20.2B | $23.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.6B | $5.6B | $17.7B | $8.2B | $6.8B | |
| Short Term Investments | $31M | $35M | $223M | $45M | $4M | |
| Accounts Receivable, Net | $11.5B | $18.4B | $20.5B | $19.9B | $20.7B | |
| Inventory | $5.7B | $6.8B | $8.2B | $8.6B | $9.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.3B | $2.8B | $3.7B | $4.4B | $4.4B | |
| Total Current Assets | $26.1B | $33.7B | $50.3B | $41.1B | $40.9B | |
| Property Plant And Equipment | $156.6B | $147B | $143.6B | $153.6B | $147.8B | |
| Long-Term Investments | $39.1B | $40.7B | $45.2B | $46.8B | $47.4B | |
| Goodwill | $4.4B | $4.4B | $4.7B | $4.7B | $4.6B | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $13.1B | $13.2B | $12.7B | $14.4B | $15.3B | |
| Total Assets | $239.8B | $239.5B | $257.7B | $261.6B | $256.9B | |
| Accounts Payable | $11B | $16.5B | $19B | $20.4B | $22.1B | |
| Accrued Expenses | $7.8B | $7B | $7.5B | $7.7B | $8.5B | |
| Current Portion Of Long-Term Debt | $1.4B | $208M | $1.9B | $469M | $4.3B | |
| Current Portion Of Capital Lease Obligations | $186M | $48M | $45M | $60M | $58M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $22.2B | $26.8B | $34.2B | $32.3B | $38.6B | |
| Long-Term Debt | $42.3B | $30.7B | $21B | $19.7B | $19.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $107.1B | $99.6B | $97.5B | $99.7B | $103.8B | |
| Common Stock | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| Other Common Equity Adj | -- | -- | -$12M | $5M | -$14M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1B | $873M | $960M | $972M | $839M | |
| Total Equity | $132.7B | $139.9B | $160.2B | $161.9B | $153.2B | |
| Total Liabilities and Equity | $239.8B | $239.5B | $257.7B | $261.6B | $256.9B | |
| Cash and Short Terms | $5.6B | $5.7B | $17.9B | $8.2B | $6.8B | |
| Total Debt | $43.7B | $30.9B | $22.9B | $20.2B | $23.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5.6B | $15.7B | $35.6B | $21.4B | $17.7B | |
| Depreciation & Amoritzation | $16.2B | $16.9B | $14.8B | $14.6B | $16.2B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $2.7B | -$7.5B | -$2.2B | $1.3B | -$818M | |
| Change in Inventories | $284M | -$530M | -$930M | -$320M | -$574M | |
| Cash From Operations | $10.6B | $29.2B | $49.6B | $35.6B | $31.5B | |
| Capital Expenditures | $8.9B | $8.1B | $12B | $15.8B | $16.4B | |
| Cash Acquisitions | $450M | $439M | -$1.7B | $278M | $195M | |
| Cash From Investing | -$7B | -$5.9B | -$12.1B | -$15.2B | -$8.9B | |
| Dividends Paid (Ex Special Dividend) | -$9.7B | -$10.2B | -$11B | -$11.3B | -$11.8B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $23.2B | $4.4B | $263M | $285M | $6.2B | |
| Long-Term Debt Repaid | -$15.7B | -$17.4B | -$8.7B | -$4.3B | -$2.6B | |
| Repurchase of Common Stock | -$1.8B | -$1.4B | -$11.3B | -$14.9B | -$15.2B | |
| Other Financing Activities | -$24M | -$36M | -$114M | -$40M | -$340M | |
| Cash From Financing | -$3.7B | -$23.1B | -$25B | -$30.1B | -$23.5B | |
| Beginning Cash (CF) | $6.9B | $6.7B | $6.8B | $19.1B | $9.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$124M | $209M | $12.5B | -$9.7B | -$916M | |
| Ending Cash (CF) | $6.7B | $6.8B | $19.1B | $9.3B | $8.3B | |
| Levered Free Cash Flow | $1.7B | $21.1B | $37.6B | $19.8B | $15B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$656M | $5.1B | $6.4B | $2.2B | $3.3B | |
| Depreciation & Amoritzation | $1.1B | $3.8B | $3.3B | $3.5B | $3.9B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$966M | -$1.8B | $2.1B | $2.2B | -$1.2B | |
| Change in Inventories | $83M | -$177M | $1.2B | $816M | $539M | |
| Cash From Operations | $2.2B | $9.5B | $12.5B | $12.4B | $8.7B | |
| Capital Expenditures | $2.1B | $2.6B | $3.8B | $4.4B | $4.3B | |
| Cash Acquisitions | $383M | $416M | $121M | $31M | $72M | |
| Cash From Investing | -$690M | -$1.4B | -$3.7B | -$4.1B | $2.7B | |
| Dividends Paid (Ex Special Dividend) | -$2.5B | -$2.6B | -$2.7B | -$2.8B | -$2.9B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.1B | -$1M | -$15M | $135M | $168M | |
| Long-Term Debt Repaid | -$2.3B | -$6B | -$293M | -$100M | -$1.6B | |
| Repurchase of Common Stock | -$6M | -$750M | -$3.8B | -$3.4B | -$4.5B | |
| Other Financing Activities | -$14M | -$2M | -$11M | $4M | -$143M | |
| Cash From Financing | -$2.7B | -$8.3B | -$6.4B | -$6.2B | -$8.8B | |
| Beginning Cash (CF) | $7.8B | $7B | $16.7B | $7B | $5.8B | |
| Foreign Exchange Rate Adjustment | $83M | -$9M | $87M | $73M | -$85M | |
| Additions / Reductions | -$1.1B | -$221M | $2.3B | $2.2B | $2.6B | |
| Ending Cash (CF) | $6.7B | $6.8B | $19.1B | $9.3B | $8.3B | |
| Levered Free Cash Flow | $171M | $6.9B | $8.7B | $8.1B | $4.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5.6B | $15.7B | $35.6B | $21.4B | $17.7B | |
| Depreciation & Amoritzation | $16.2B | $16.9B | $14.8B | $14.6B | $16.2B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $2.7B | -$7.5B | -$2.2B | $1.3B | -$818M | |
| Change in Inventories | $284M | -$530M | -$930M | -$320M | -$574M | |
| Cash From Operations | $10.6B | $29.2B | $49.6B | $35.6B | $31.5B | |
| Capital Expenditures | $8.9B | $8.1B | $12B | $15.8B | $16.4B | |
| Cash Acquisitions | $450M | $439M | -$1.7B | $278M | $195M | |
| Cash From Investing | -$7B | -$5.9B | -$12.1B | -$15.2B | -$8.9B | |
| Dividends Paid (Ex Special Dividend) | -$9.7B | -$10.2B | -$11B | -$11.3B | -$11.8B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $23.2B | $4.4B | $263M | $285M | $6.2B | |
| Long-Term Debt Repaid | -$15.7B | -$17.4B | -$8.7B | -$4.3B | -$2.6B | |
| Repurchase of Common Stock | -$1.8B | -$1.4B | -$11.3B | -$14.9B | -$15.2B | |
| Other Financing Activities | -$24M | -$36M | -$114M | -$40M | -$340M | |
| Cash From Financing | -$3.7B | -$23.1B | -$25B | -$30.1B | -$23.5B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$124M | $209M | $12.5B | -$9.7B | -$916M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.7B | $21.1B | $37.6B | $19.8B | $15B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.7B | $35.6B | $21.4B | $17.7B | -- | |
| Depreciation & Amoritzation | $16.9B | $14.8B | $14.6B | $16.2B | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$7.5B | -$2.2B | $1.3B | -$818M | -- | |
| Change in Inventories | -$530M | -$930M | -$320M | -$574M | -- | |
| Cash From Operations | $29.2B | $49.6B | $35.6B | $31.5B | -- | |
| Capital Expenditures | $8.1B | $12B | $15.8B | $16.4B | -- | |
| Cash Acquisitions | $439M | -$1.7B | $278M | $195M | -- | |
| Cash From Investing | -$5.9B | -$12.1B | -$15.2B | -$8.9B | -- | |
| Dividends Paid (Ex Special Dividend) | -$10.2B | -$11B | -$11.3B | -$11.8B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $4.4B | $263M | $285M | $6.2B | -- | |
| Long-Term Debt Repaid | -$17.4B | -$8.7B | -$4.3B | -$2.6B | -- | |
| Repurchase of Common Stock | -$1.4B | -$11.3B | -$14.9B | -$15.2B | -- | |
| Other Financing Activities | -$36M | -$114M | -$40M | -$340M | -- | |
| Cash From Financing | -$23.1B | -$25B | -$30.1B | -$23.5B | -- | |
| Beginning Cash (CF) | $30.7B | $49.7B | $53.4B | $27.2B | -- | |
| Foreign Exchange Rate Adjustment | -$151M | -$190M | -$114M | -$97M | -- | |
| Additions / Reductions | $209M | $12.5B | -$9.7B | -$916M | -- | |
| Ending Cash (CF) | $30.8B | $62B | $43.6B | $26.2B | -- | |
| Levered Free Cash Flow | $21.1B | $37.6B | $19.8B | $15B | -- | |
Get CVX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CVX
Sector
P/E ratio
17.15x
11.14x
PEG ratio
--
0.02x
P/B ratio
1.93x
1.07x
Price / LTM sales
1.57x
0.92x
Growth Metrics
CVX
Sector
Revenue growth
-1.22%
-4%
Earnings growth
50.82%
-20.83%
Revenue (5-year growth)
6.7%
6.7%
Earnings forecast
$2.11
$0.22
Profitability
CVX
Sector
Profitability FY 2024
$56.9B
$108.4M
Return on invested capital
9.71%
3.75%
Return on assets
6.79%
2.52%
Return on equity
11.12%
5.78%
Earnings Date
Last Earnings Date
Jan
31
Next Earnings Date
Apr
25
Estimated Next Earnings Date
May
2
Balance Sheet
CVX
Sector
Total cash
$6.8B
$14.9M
Short term investments
$4M
$4M
Total assets
$256.9B
$404.6M
Long term debt
$23.9B
$122.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is up 0.71% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
